Combined cis-regulator elements as important mechanism affecting FXII plasma levels

Thrombosis Research

Volumn 125, Issue 2, 2010, Pages

  Sabater Lleal, Maria ^a   Chillón, Miguel ^b,c   Mordillo, Carolina ^d   Martínez, Ángel ^a   Gil, Estel ^c   Mateo, José ^d   Blangero, John ^e   Almasy, Laura ^e   Fontcuberta, Jordi ^d   Soria, José Manuel ^a  

^a Institut de Recerca   (Spain)

^b INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^e SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

F12; Genetic analyses; Promoter expression; Thrombophilia

Indexed keywords

BLOOD CLOTTING FACTOR 12; HEPATOCYTE NUCLEAR FACTOR 4; NUCLEAR PROTEIN;

ADOLESCENT; ADULT; ARTICLE; BINDING SITE; BLOOD CLOTTING FACTOR 12 DEFICIENCY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ETHNIC GROUP; FAMILY; FEMALE; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE PHENOTYPE CORRELATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MOLECULAR CLONING; PRESCHOOL CHILD; PRIORITY JOURNAL; PROMOTER REGION; RISK; THROMBOSIS; WILD TYPE;

CHILD; CLONING, MOLECULAR; FACTOR XII; FACTOR XII DEFICIENCY; FEMALE; GENES, REPORTER; GENOTYPE; HUMANS; MIDDLE AGED; MUTATION; PEDIGREE; PHENOTYPE; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; SPAIN;

EID: 76449089721     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2009.08.019     Document Type: Article

References (30)

1. Furie B., and Furie B.C. The molecular basis of blood coagulation. Cell 53 4 (1988) 505-518
2. Wiggins R.C., Bouma B.N., Cochrane C.G., and Griffin J.H. Role of high-molecular-weight kininogen in surface-binding and activation of coagulation Factor XI and prekallikrein. Proc Natl Acad Sci U S A 74 10 (1977) 4636-4640
3. Griffin J.H. Role of surface in surface-dependent activation of Hageman factor (blood coagulation factor XII). Proc Natl Acad Sci U S A 75 4 (1978) 1998-2002
4. Halbmayer W.M., Mannhalter C., Feichtinger C., Rubi K., and Fischer M. The prevalence of factor XII deficiency in 103 orally anticoagulated outpatients suffering from recurrent venous and/or arterial thromboembolism. Thromb Haemost 68 3 (1992) 285-290
5. Doggen C.J., Rosendaal F.R., and Meijers J.C. Levels of intrinsic coagulation factors and the risk of myocardial infarction among men: Opposite and synergistic effects of factors XI and XII. Blood 108 13 (2006) 4045-4051
6. Santamaria A., Mateo J., Tirado I., Oliver A., Belvis R., Marti-Fabregas J., et al. Homozygosity of the T allele of the 46 C->T polymorphism in the F12 gene is a risk factor for ischemic stroke in the Spanish population. Stroke 35 8 (2004) 1795-1799
7. Zeerleder S., Schloesser M., Redondo M., Wuillemin W.A., Engel W., Furlan M., et al. Reevaluation of the incidence of thromboembolic complications in congenital factor XII deficiency-a study on 73 subjects from 14 Swiss families. Thromb Haemost 82 4 (1999) 1240-1246
8. Gailani D., and Renne T. Intrinsic pathway of coagulation and arterial thrombosis. Arterioscler Thromb Vasc Biol 27 12 (2007) 2507-2513
9. Endler G., Marsik C., Jilma B., Schickbauer T., Quehenberger P., and Mannhalter C. Evidence of a U-shaped association between factor XII activity and overall survival. J Thromb Haemost 5 6 (2007) 1143-1148
10. Lane D.A., Mannucci P.M., Bauer K.A., Bertina R.M., Bochkov N.P., Boulyjenkov V., et al. Inherited thrombophilia: Part 1. Thromb Haemost 76 5 (1996) 651-662
11. Lane D.A., Mannucci P.M., Bauer K.A., Bertina R.M., Bochkov N.P., Boulyjenkov V., et al. Inherited thrombophilia: Part 2. Thromb Haemost 76 6 (1996) 824-834
12. Soria J.M., Almasy L., Souto J.C., Bacq D., Buil A., Faure A., et al. A quantitative-trait locus in the human factor XII gene influences both plasma factor XII levels and susceptibility to thrombotic disease. Am J Hum Genet 70 3 (2002) 567-574
13. Mordillo C., Martinez-Marchan E., Fontcuberta J., and Soria J.M. Molecular analysis of multiple genetic variants in Spanish FXII-deficient families. Haematologica 92 11 (2007) 1569-1572
14. Lombardi A.M., Bortoletto E., Scarparo P., Scapin M., Santarossa L., and Girolami A. Genetic study in patients with factor XII deficiency: a report of three new mutations exon 13 (Q501STOP), exon 14 (P547L) and -13C>T promoter region in three compound heterozygotes. Blood Coagul Fibrinolysis 19 7 (2008) 639-643
15. Miller S.A., Dykes D.D., and Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16 3 (1988) 1215
16. Souto J.C., Almasy L., Borrell M., Gari M., Martinez E., Mateo J., et al. Genetic determinants of hemostasis phenotypes in Spanish families. Circulation 101 13 (2000) 1546-1551
17. den Dunnen J.T., and Antonarakis S.E. Nomenclature for the description of human sequence variations. Hum Genet 109 1 (2001) 121-124
18. Goula D., Remy J.S., Erbacher P., Wasowicz M., Levi G., Abdallah B., et al. Size, diffusibility and transfection performance of linear PEI/DNA complexes in the mouse central nervous system. Gene Ther 5 5 (1998) 712-717
19. Taupin J.L., Merville P., McBride T., Potaux L., and Moreau J.F. Functional quantification of cyclosporine A and FK506 in human whole blood by flow cytometry, using the green fluorescent protein as an interleukin-2 reporter gene. J Immunol Methods 256 1-2 (2001) 77-87
20. Niswender K.D., Blackman S.M., Rohde L., Magnuson M.A., and Piston D.W. Quantitative imaging of green fluorescent protein in cultured cells: comparison of microscopic techniques, use in fusion proteins and detection limits. J Microsc 180 Pt 2 (1995) 109-116
21. Sabater-Lleal M., Chillon M., Howard T.E., Gil E., Almasy L., Blangero J., et al. Functional analysis of the genetic variability in the F7 gene promoter. Atherosclerosis 197 2 (2007) 262-268
22. Sladek F.M., Ruse Jr. M.D., Nepomuceno L., Huang S.M., and Stallcup M.R. Modulation of transcriptional activation and coactivator interaction by a splicing variation in the F domain of nuclear receptor hepatocyte nuclear factor 4alpha1. Mol Cell Biol 19 10 (1999) 6509-6522
23. Inoue Y., Peters L.L., Yim S.H., Inoue J., and Gonzalez F.J. Role of hepatocyte nuclear factor 4alpha in control of blood coagulation factor gene expression. J Mol Med 84 4 (2006) 334-344
24. Kanaji T., Okamura T., Osaki K., Kuroiwa M., Shimoda K., Hamasaki N., et al. A common genetic polymorphism (46 C to T substitution) in the 5'-untranslated region of the coagulation factor XII gene is associated with low translation efficiency and decrease in plasma factor XII level. Blood 91 6 (1998) 2010-2014
25. Endler G., Exner M., Mannhalter C., Meier S., Ruzicka K., Handler S., et al. A common C->T polymorphism at nt 46 in the promoter region of coagulation factor XII is associated with decreased factor XII activity. Thromb Res 101 4 (2001) 255-260
26. White R.H. The epidemiology of venous thromboembolism. Circulation 107 23 Suppl 1 (2003) I4-I8
27. Anderson Jr. F.A., and Spencer F.A. Risk factors for venous thromboembolism. Circulation 107 23 Suppl 1 (2003) I9-I16
28. Iyengar S.K., and Elston R.C. The genetic basis of complex traits: rare variants or "common gene, common disease"?. Methods Mol Biol 376 (2007) 71-84
29. Bodmer W., and Bonilla C. Common and rare variants in multifactorial susceptibility to common diseases. Nat Genet 40 6 (2008) 695-701
30. Hirschhorn J.N., and Daly M.J. Genome-wide association studies for common diseases and complex traits. Nat Rev Genet 6 2 (2005) 95-108